GSE213588 trametinib NF1 8 v 11 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE213588_trametinib_NF1_8_v_11_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE213588_trametinib_NF1_8_v_11_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE213588_trametinib_NF1_8_v_11_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE213588_trametinib_NF1_8_v_11_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

MIR4435-2 host gene

Gene

small nucleolar RNA host gene 1

Gene

differentiation antagonizing non-protein coding RNA

Gene

small nucleolar RNA host gene 3

Gene

small nucleolar RNA host gene 16

Gene

H3.7 histone (putative)

Gene

multidrug resistance-related protein

Gene

small nucleolar RNA host gene 15

Gene

SBDS pseudogene 1

Gene

deleted in lymphocytic leukemia 2


  • Gene

    small nucleolar RNA host gene 1


  • Gene

    differentiation antagonizing non-protein coding RNA


  • Gene

    small nucleolar RNA host gene 3


  • Gene

    small nucleolar RNA host gene 16


  • Gene

    H3.7 histone (putative)


  • Gene

    multidrug resistance-related protein


  • Gene

    small nucleolar RNA host gene 15


  • Gene

    SBDS pseudogene 1


  • Gene

    deleted in lymphocytic leukemia 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.